CLINICAL_TRIALS
trial_result
· 2023-04-10
Clinical Trial Update: Roll-over Study to Assess Safety of Lixivaptan in Participants With ADPKD Who Completed Study PA-ADPKD-303 [Phase 3]
Summary
Roll-over Phase 3 safety study of lixivaptan in adults with autosomal dominant polycystic kidney disease (ADPKD) completed participation; trial terminated with …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Palladio Biosciences | Conditions: Polycystic Kidney Disease, Adult | Phase 3 | Status: TERMINATED | Results posted: 2023-04-10